Moderna

First Opinion By Kristen Riemenschneider

Is it time for big biopharma companies to rethink the use of federal funding for R&D?

First Opinion By Jeff Fischer

Uncorking today’s Covid-19 supply chain to meet the challenges of future pandemics

Health By Helen Branswell

U.S. would seek global approach to updating Covid-19 vaccines, official says

Health Tech By Olivia Goldhill

Wary of a backlash, telehealth startups focused on women’s sexual health steer clear of abortion pills

In the Lab By Rebecca Ostriker and Deirdre Fernandes — The Boston Globe

Real estate developer reneges on multimillion-dollar pledge to Harvard-led Covid project

Pharmalot By Ed Silverman

At Davos, a ‘good news, bad news’ message emerges about Covid-19

First Opinion By Hillary Omala and Eddah Ogogo

Fighting Covid-19 in Kibera, one of Africa’s largest informal settlements

Health By Mike Stobbe — Associated Press

CDC encourages more Americans to consider N95 masks